Live Clinical Webinar | Thursday, June 11, 2026 | 07:00 PM EST
Most patients with tick-borne illness are not undiagnosed because providers do not care. They are undiagnosed because the right testing question was never asked.
This session walks through two real case types. A molecular positive and a negative with high clinical suspicion and shows exactly how Dr. Chris Turnpaugh thinks through diagnosis, interprets Galaxy direct detection results, and builds a protocol.
Presented in Partnership With:
In this clinical webinar, Dr. Chris Turnpaugh, DC, DACNB, AFMCP, founder of Turnpaugh Health and Wellness Center and a nationally recognized expert in functional and integrative medicine walks through a practical, case-based framework for evaluating and treating tick-borne illness.
Most providers have a clinical instinct when they suspect a vector-borne pathogen. What they are often missing is a clear, step-by-step protocol for what to do with the diagnostic result whether it is positive, negative, or ambiguous.
Using Galaxy Diagnostics direct detection technology and Quicksilver Scientific’s phase-based protocol system, this session gives clinicians a reproducible framework they can apply immediately with complex patients.
Why serology answers a historical question and what direct detection answers instead
How to interpret a molecular positive: which pathogens were found and what protocol response is clinically appropriate
How to navigate a negative result with high clinical suspicion when to treat empirically and how to document that decision
How Galaxy’s Triple Draw BBB Direct Detect and Lyme Borrelia Direct Detect work, and when to use each
The Quicksilver Scientific three-phase protocol (Prep and Detox, Anti-Microbial, Recovery) and how to adapt it case by case
Why two phases of tick-borne illness often require two distinct treatment tracks
How to identify when immune dysregulation, not active infection, is the primary driver of ongoing symptoms
The acute bookend: what to do in the first 72 hours after a tick bite, before chronic illness develops
Integrative and functional medicine clinicians
Naturopathic physicians
Primary care providers managing complex chronic patients.
Lyme-literate and vector-borne disease specialists.
Any clinician who has received a direct detection result and wanted more guidance interpreting or acting on it
Providers who currently use or are considering Galaxy Diagnostics testing
This session is intended for clinicians and licensed healthcare providers only.
Dr. Chris Turnpaugh, DC, DACNB, AFMCP is the founder and president of Turnpaugh Health and Wellness Center and a leading voice in functional medicine for complex chronic conditions.
With over 25 years of clinical experience, Dr. Turnpaugh specializes in autoimmune disease, neurological disorders, thyroid dysfunction, and tick-borne illness.
He holds post-doctoral certification in functional neurology from the Carrick Institute, is certified through the Institute for Functional Medicine (AFMCP), and is a member of ILADs, A4M, and the Institute for Functional Medicine.
Dr. Turnpaugh teaches healthcare providers across the country and brings both clinical depth and practical clarity to every case he presents.
Presented in partnership with Galaxy Diagnostics and Quicksilver Scientific.
Access to the live webinar
Reminder emails and the live event link
On-demand replay following the session.
Downloadable presentation slides
Galaxy Diagnostics test ordering reference guide
Quicksilver Scientific tick-borne illness protocol summary
Additional clinical resources for complex case management
Galaxy Diagnostics advances the detection of elusive vector-borne pathogens through transparent, evidence-driven science, empowering clinicians to diagnose confidently in complex or uncertain presentations.
Our lab will be closed on Friday, June 19th, in observance of Juneteenth. Normal operations resume Monday, June 22nd.
If you have questions or concerns, please reach out to our office at [email protected].
Ship all specimens by Wednesday, June 17th, to avoid processing delays.
